Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00389350 · ClinicalTrials.gov registry record · Phase 2

Effect of an Extract of Green Tea on Adults With Type 2 Diabetes

A Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
Phase 2
Development phase
48
Enrollment target

NCT00389350: Completed Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT00389350 is a Phase 2 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 48 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00389350, a Phase 2 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
48 participants
Enrollment target

Study Summary

The objective of this study was to determine if taking an extract of green tea for three months could improve glucose control in adults with diabetes.

Interventions

  • DRUG Extract of Green and Black Tea

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2005-08
Est. Completion 2006-06
Phase Phase 2
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT00389350 record still lists

NCT00389350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 1 intervention - of which Extract of Green and Black Tea is the first listed.

NCT00389350 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00389350 about?

NCT00389350 is a clinical study titled "Effect of an Extract of Green Tea on Adults With Type 2 Diabetes". The objective of this study was to determine if taking an extract of green tea for three months could improve glucose control in adults with diabetes.

What is the current status of trial NCT00389350?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2005-08. Estimated completion is 2006-06.

What interventions are being tested in trial NCT00389350?

The interventions under investigation include: Extract of Green and Black Tea (DRUG).

Who is sponsoring clinical trial NCT00389350?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00389350's enrollment target sits among peer trials

48 1265th of 2000 higher than 718 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00389350, the US trial registry maintained by the National Library of Medicine. NCT00389350 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.